天美传媒

Dr. Rupp is a Professor in the Department of Internal Medicine, Section of Infectious Diseases at the University of Nebraska Medical Center. He is the Medical Director of The Nebraska Medical Center Department of Healthcare Epidemiology and co-Director of the Antimicrobial Stewardship Program.

Dr. Rupp received his medical degree from Baylor College of Medicine, Houston, Texas and holds a B.S. degree in Chemical Engineering from the University of Texas, Austin, Texas. He underwent internship and residency training in Internal Medicine at Virginia Commonwealth University and completed a Fellowship in Infectious Diseases at VCU.

He is a Diplomate, American Board of Internal Medicine, and in the subspecialty area of Infectious Diseases. He is a Fellow of the Society for Hospital Epidemiology of America (SHEA), American College of Physicians (ACP), and the Infectious Diseases Society of America (IDSA). He is a Past-President of SHEA and is a past-president of ASM Division L (Infection Control/Hospital Epidemiology). Dr Rupp has served as a consultant for the US Food and Drug Administration as well as the Centers for Disease Control and Prevention.

Dr. Rupp has published over 300 articles, chapters and abstracts and is the editor of a textbook entitled 鈥淏iofilms, Infections, and Antimicrobial Therapy.鈥� He frequently presents papers at national and international meetings, serves as a guest lecturer, and is an active teacher and researcher. Dr. Rupp鈥檚 research interests are in the areas of staphylococcal disease, healthcare-associated infections, and antimicrobial resistance.

Dr. Faisal Masud serves as Board Member, Houston Methodist Board of Directors, and Medical Director of Center for Critical Care at Houston Methodist Hospital System overseeing 8 hospitals ICU鈥檚 and V-ICU. He also serves as Vice-Chair for Quality and Patient Safety, the Associate Quality Officer, and Medical Director, Cardiovascular Intensive Care Unit, Methodist DeBakey Heart & Vascular Center. He is Professor of Clinical Anesthesiology, Weill Cornell Medical College, Professor of Anesthesiology at Houston Methodist Institute of Academic Medicine, and Professor in the Department of Acute & Continuing Care at UT-Houston. He received his training at Duke University Medical Center and Cleveland Clinic Foundation.

Among his many awards is Presidential Gold Medal. He has been the recipient of the Golden Apple Award for Excellence in Teaching four times, the Dean H. Morrow Resident Mentor Award in 2001, and the most prestigious Fulbright & Jaworski Faculty Excellence Award in Educational Leadership. He was elected a member of the Academy of Distinguished Educators at Baylor College of Medicine. He received the Association of Professional in Infection Control (APIC) National award for Heroes in Infection Prevention 2010. He is also a recipient of the Overstreet Award for exemplifying the best of the medical profession.

Dr. Masud's leadership resulted in great improvements in patient care and clinical outcomes, in patient safety & quality, sepsis control, central line infections, ventilator associated pneumonia, surgical site infections, blood transfusions, pharmacy etc. resulting hundreds of lives saved and millions of dollar in cost savings.

His focus is on improving healthcare in underdeveloped health systems in less developed countries and has been doing volunteer work to improve healthcare in vulnerable areas for many years. He is also the Board Member of Shifa USA a Houston based charitable organization providing free medical and dental care, women shelter, etc.

He has many research projects, publications and is an invited faculty at multiple local, state, national meetings and international conferences and meetings including Canada, Malaysia, Israel, China, Pakistan, Brazil, Dubai, and Saudi Arabia.

Dr. Stibich is an infectious diseases epidemiologist, founder and Chief Scientific Officer for Xenex Disinfection Services, the world leader in UV disinfection for healthcare facilities. Xenex's LightStrike Germ-Zapping Robots are used by hundreds of healthcare facilities (and now office buildings, schools, professional sports teams, hotels, police stations, correctional facilities, airports and convention centers) to reduce the microbial contamination from "superbugs" such as MRSA, VRE and C. diff. The LightStrike robot is proven to deactivate SARS-CoV-2 (the virus that causes COVID-19) in 2 minutes. More than 40 peer-reviewed studies documenting the robot's efficacy have been published in scientific journals. 

Dr. Stibich specializes in creating efficient solutions for public health problems. He received his doctoral training from the Johns Hopkins School of Public Health and has been involved in numerous international research and intervention projects. He is an inventor on over 125 patents relating to infection prevention, a principal investigator on an NIH grant, and was a visiting scientist at MD Anderson Cancer Center.

A Fellow of the Infectious Diseases Society of America and a Fellow with the Royal Society of Medicine, Dr. Stibich  is a frequent speaker and has presented for many organizations including TEDx, DENT and the Royal Society of Medicine.   

Katherine Baumgarten, MD, is board certified in internal medicine and infectious diseases, and has served as Ochsner Health medical director of infection prevention since 2008. Her expertise includes health care safety and clinical infectious diseases, along with emerging infections and adult vaccines. She has been interviewed by Newsweek magazine, CNN and numerous local outlets on COVID-19, measles and bird flu, among other topics. 
Dr. Baumgarten is a fellow of both the American College of Physicians and the Infectious Diseases Society of America. She is a member of the Society for Healthcare Epidemiology of America and the American Board of Internal Medicine.
A New Orleans native, she attended Washington and Lee University in Lexington, Virginia, and earned a medical degree from Louisiana State University Health Sciences Center - New Orleans. She completed an internship and residency at the University of California at San Francisco and completed an infectious diseases fellowship at Ochsner Medical Foundation in New Orleans.

, is a professor of clinical medicine in the Department of Medicine, Division of Infectious Diseases at the University of California, San Diego. She sees patients in the Owen Clinic and the infectious diseases clinic. She also cares for people during hospital stays.
Dr. Torriani is medical director of the UC San Diego Infection Prevention and Clinical Epidemiology and the tuberculosis control units at UC San Diego Health. In collaboration with Atlas Public Health, she has been instrumental in creating an extensive electronic microbiology surveillance and pharmacy utilization program called Guardian that allows for internal data mining, surveillance, unit-specific antibiogram production, and external reporting of contagious infections to San Diego Public Health and to the California Department of Public Health (CDPH) of Healthcare Associated Infections (HAI).
Since 2010, Dr. Torriani has served on the Metrics Group for CA HAI Reporting, an independent group of experts discussing best standards and methods for HAI reporting in California. 
She is fluent in five languages: Italian, French, German, Spanish and English.